A review of dengue fever: A resurging tropical disease

Pediatric Emergency Care

Volumn 29, Issue 5, 2013, Pages 665-672

  Mangold, Karen A ^a   Reynolds, Sally L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Dengue fever; Dengue hemorrhagic fever; Dengue shock syndrome; Mosquito borne illness

Indexed keywords

ARTHRALGIA; BED NET; CLINICAL FEATURE; DENGUE; EPISTAXIS; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HEMORRHAGIC FEVER; HUMAN; MORTALITY; MOSQUITO; MYALGIA; NAUSEA; PURPURA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SHOCK; SORE THROAT; UNITED STATES; VAGINA BLEEDING; VOMITING;

ACETAMINOPHEN; AEDES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, VIRAL; ASIA; CARIBBEAN REGION; DENGUE; DENGUE VACCINES; DENGUE VIRUS; DIAGNOSIS, DIFFERENTIAL; ENDEMIC DISEASES; FEVER; HUMANS; INSECT VECTORS; LATIN AMERICA; RECURRENCE; RNA, VIRAL; SEROTYPING; SEVERE DENGUE;

EID: 84877751942     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0b013e31828ed30e     Document Type: Review

References (24)

1. WHO. Dengue and Dengue Hemorrhagic Fever Factsheet No 117. Revised May 2008; Available at : Http://www.who.int/mediacentre/ factsheets/fs117/en/. Accessed June 16, 2011.
2. Wilson ME, Weld LH, Boggild A, et al. Fever in returned travelers: Results from the GeoSentinel Surveillance Network. Clin Infect Dis. 2007;44:1560Y1568.
3. Cobelens FG, Groen J, Osterhaus AD, et al. Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia. Trop Med Int Health. 2002;7:331Y338.
4. Potasman I, Srugo I, Schwartz E. Dengue seroconversion among Israeli travelers to tropical countries. Emerg Infect Dis. 1999;5:824Y827.
5. WHO. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. France: World Health Organization; 2009.
6. San Martin JL, Brathwaite O, Zambrano B, et al. The epidemiology of dengue in the Americas over the last three decades: A worrisome reality. Am J Trop Med Hyg. 2010;82:128Y135.
7. Travel-associated dengueVUnited States, 2005. MMWR Morb Mortal Wkly Rep. 2006;55:700Y702.
8. Travel-associated dengue infectionsVUnited States, 2001Y2004. MMWR Morb Mortal Wkly Rep. 2005;54:556Y558.
9. Ross TM. Dengue virus. Clin Lab Med. 2010;30:149Y160.
10. Chen LH, Wilson ME. Dengue and chikungunya infections in travelers. Curr Opin Infect Dis. 2010;23:438Y444.
11. Tomashek KM. Dengue Fever and Degue Hemorrhagic Fever. 2009; Available at: Http://wwwnc.cdc.gov/travel/yellowbook/2010/chapter-5/dengue-fever-dengue- hemorrhagic-fever.htm. Accessed June 23, 2011.
12. Rigau-Perez JG, Clark GG, Gubler DJ, et al. Dengue and dengue haemorrhagic fever. Lancet. 1998;352:971Y977.
13. Cao XT, Ngo TN, Wills B, et al. Evaluation of the World Health Organization standard tourniquet test and a modified tourniquet test in the diagnosis of dengue infection in Viet Nam. Trop Med Int Health. 2002;7:125Y132.
14. Kabra SK, Jain Y, Pandey RM, et al. Dengue haemorrhagic fever in children in the 1996 Delhi epidemic. Trans R Soc Trop Med Hyg. 1999;93:294Y298.
15. Kalayanarooj S, Vaughn DW, Nimmannitya S, et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis. 1997;176:313Y321.
16. Gregory CJ, Santiago LM, Arguello DF, et al. Clinical and laboratory features that differentiate dengue from other febrile illnesses in an endemic areaVPuerto Rico, 2007Y2008. Am J Trop Med Hyg. 2010;82:922Y929.
17. Guzman MG, Kouri G. Advances in dengue diagnosis. Clin Diagn Lab Immunol. 1996;3:621Y627.
18. De Paula SO, Pires Neto RJ, Correa JA, et al. The use of reverse transcriptionYpolymerase chain reaction (RT-PCR) for the rapid detection and identification of dengue virus in an endemic region: A validation study. Trans R Soc Trop Med Hyg. 2002;96:266Y269.
19. Chanama S, Anantapreecha S, A-nuegoonpipat A, et al. Analysis of specific IgM responses in secondary dengue virus infections: Levels and positive rates in comparison with primary infections. J Clin Virol. 2004;31:185Y189.
20. Halstead SB. Etiologies of the experimental dengues of Siler and Simmons. Am J Trop Med Hyg. 1974;23:974Y982.
21. Halstead SB, Nimmannitya S, Cohen SN. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med. 1970;42:311Y328.
22. Halstead SB, Heinz FX, Barrett AD, et al. Dengue virus: Molecular basis of cell entry and pathogenesis, 25Y27 June 2003, Vienna, Austria. Vaccine. 2005;23:849Y856.
23. Ubol S, Phuklia W, Kalayanarooj S, et al. Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies. J Infect Dis. 2010;201:923Y935.
24. Halstead SB, Deen J. The future of dengue vaccines. Lancet. 2002;360 1243-124n1.